“I’m an on-the-go woman.
A once-a-year osteoporosis treatment fits my life.”
Im p o rta n t in fo rm a tio n :
“
I'm Jane. I'v e got osteoporosis.
A fter work at the botanical garden,
I often go swim ming.
A n d I love going out at night
w ith my frien d s to hear ja z z .
I'm always on the go. ”
D iscover ^
— *
R e c la s t
(zoledronic add) injection
5
m g /io o m L fo r in fu s io n
Reclast is a prescription medication that treats
postmenopausal osteoporosis.
•
One intravenous (IV) dose a year helps
strengthen bones and protect them from fracture,
when taken with daily calcium and vitamin D
•
No other osteoporosis treatment is approved to
help protect from fracture in more places: hip,
spine, even other bones
•
IV given by a doctor or nurse for no less than
15 minutes once a year
Ask your doctor if Reclast is right for you.
1-866-Reclast
•
www.reclast.com
You should not take Reclast if you’re on Zometa® (zoledronic acid) Injection as it contains the same
ingredient; if you have low blood calcium, kidney problems, or are allergic to Reclast or Zometa. Or you’re
pregnant, plan to become pregnant or nursing.
It’s important to drink fluids before getting Reclast to help prevent kidney problems. The most common side
effects are flu-like symptoms, fever, muscle or joint pain and headache. Tell your doctor if you have dental
problems because rarely, problems with the jaw have been reported with Reclast. Discuss all medicines you’re
taking, including prescription and non-prescription, vitamins and herbal supplements. If you develop severe
bone, joint or muscle pain, numbness, tingling or muscle spasms, contact your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call
1
-
800
-FDA-
1088
.
If you don’t have prescription coverage and can’t afford your medicines, log onto www.pap.novartis.com or call
1
-
800
-
245
-
5356
.
R e c l a s t . Y e a r - l o n g p r o t e c t io n f o r o n - t h e - g o w o m e n .
Please see next page for important product information.
©2008
Novartis Printed
in
U
.S.A
.
9/08
RST
-800358
